A Resource for Healthcare and Social Services Professionals
January 18, 2023
3:00 pm–4:00 pm ET
This training will provide knowledge regarding Xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.
Event sold-out
Via Zoom
This training will provide knowledge regarding Xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US. This training will discuss the physiologic effects of Xylazine, manifestations of Xylazine intoxication, overdose, communicable infections associated with Xylazine use, and wound care for persons injecting Xylazine.
Providers, nurses, counselors, and other non-clinical staff are welcome to attend.
Dr. Jawa is an Assistant Professor and Clinician Investigator in the Department of General Internal Medicine at University of Pittsburgh Medical Center and a clinician investigator in the Center for Research on Health Care. She is board certified in Internal Medicine and Infectious Disease and Addiction Medicine. Dr. Jawa’s research focuses on the intersection of Infectious Disease and Addiction, including studying how to optimize integration of harm reduction services for individuals with substance use disorders within traditional health settings, developing multidisciplinary provider facing interventions so as to prevent, diagnose, and treat infectious and non-infections complications of drug use. Clinically, she provides office-based addiction treatment in IM Recovery Engagement Program and attends on the Endovascular Infection Service at UPMC.
Following this training, participants will have the knowledge necessary to:
Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Boston Medical Center grants 1.00 hours to all nurses who attend and complete the evaluation. Boston Medical Center is approved as a provider of continuing professional development by the American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
The lecture has been approved by The Network of Professional Education at Boston University School of Social Work, accredited by the Commonwealth of Massachusetts Board of Social Work Registration, to provide 1.00 credit hours.
BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs.
Event sold-out
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.